baber/WOPTO huggingface dataset:
Patent PT-1773434-E (PT)
Title: Method and apparatus for reducing noise in a roots-type blower
Inventor: DEVRIES DOUGLAS F
IPC: A61M11/00
Filed: 2004-11-10
Abstract: A Roots-type blower comprises a housing defining a rotor chamber and an inlet and outlet to the rotor chamber. First and second rotors are mounted in the rotor chamber, each rotor defining a plurality of lobes, adjacent lobes and the housing cooperating to define gas transport chambers. The blower is configured so that a net flow rate of gas into a gas transport chamber is generally or approximately constant, whereby a change in gas pressure in the gas transport chamber is generally or approximately linear, as the gas transport chamber approaches the outlet. In one embodiment, this is accomplished by providing flow channels extending from the outlet towards the inlet, and from the inlet towards the outlet, corresponding to each rotor. The flow channels permit gas to flow from the high pressure outlet to a gas transport chamber and from the gas transport chamber to the low pressure inlet. The resulting amelioration of pressure spikes associated with flow back substantially reduces the operational noise level of the blower.
Patent PT-1688040-E (PT)
Title: Pesticidal composition comprising pyriproxyfen
Inventor: TANEDANI TOSHIYUKI
IPC: A01P7/04
Filed: 2005-12-07
Abstract: A pesticidal composition comprising 4-phenoxyphenyl 2-(2-pyridyloxy)propyl ether; a hydrophobic organic solvent capable of dissolving 0.1-fold by weight of 4-phenoxyphenyl 2-(2-pyridyloxy)propyl ether at 0°C; polyvinyl alcohol; a nonionic surfactant selected from the group consisting of alkoxylated castor oil, alkoxylated hydrogenated castor oil and alkoxylated hydrogenated castor oil fatty acid ester; and water, is excellent in storage stability.
Patent PT-1910484-E (PT)
Title: Amphiphilic polymer compounds, method for the production thereof and their use
Inventor: ALBRECHT GERHARD
IPC: C04B24/24
Filed: 2006-07-20
Abstract: The invention describes amphiphilic polymer compounds which are prepared by a) reacting a di-, tri- or tetraglycidyl compound (A) with an optionally unsaturated reactive component (B) consisting of C8-C28-fatty acid, a C8-C28-alcohol or a secondary C8-C28-amine, and allowing b1) the reaction product from stage a) to react further first with b1α) an aliphatic or aromatic polyisocyanate compound (C) b1β) and optionally then with a polyalkylene oxide compound (D), and b1γ) reacting the reaction product from stage b1α) or optionally b1β) with a component (E) which is reactive towards isocyanates and has at least one OH, NH2, NH or SH group, or b2) allowing the reaction product from stage a) to react to completion with the reaction product of component (C) with component (E) and optionally (D) and (C), or b3) allowing the reaction product from stage a) to react to completion with the reaction product from component (C) and component (D) and optionally (C) and optionally the reaction product of component (C) and component (E) and optionally (C). The polymer compounds proposed according to the invention are exceptionally useful as agents for preventing or suppressing efflorescences on surfaces of hardended, hydraulically settable building materials or/and for hydrophobization of the corresponding hydraulically settable systems. Moreover, owing to the admixtures proposed according to the invention, the corresponding products absorb substantially less water, with the result that frost damage and rapid rusting of the steel reinforcement can be substantially reduced.
Patent PT-1989206-E (PT)
Title: Inhibitors of e1 activating enzyme
Inventor: LANGSTON STEVEN P
IPC: A61K31/519
Filed: 2007-01-31
Abstract: This invention relates to compounds of formula (I) that inhibit E1 activating enzymes, pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating disorders, particularly cell proliferation disorders, including cancers, inflammatory and neurodegenerative disorders; and inflammation associated with infection and cachexia.
Patent PT-2191060-E (PT)
Title: Electrically conductive, flexible web material
Inventor: RITTER WOLFGANG
IPC: A41D13/05
Filed: 2008-09-05
Abstract: An electrically conductive, flexible web material assembly includes a polymer-bonded electrically conductive coating on a flexible, electrically non-conductive carrier, and at least two electrodes for feeding electric current. The electrodes are flexible bands made of an electrically conductive material, and each electrode is fixed on the flat carrier by way of one or more stitches. At least one surface of each electrode has a surface contact with the electrically conductive coating. There are also described a variety of implementations of the electrically conductive, flexible web material assembly in heating elements and in clothing.
Patent PT-2219160-E (PT)
Title: Money-operated entertainment device
Inventor: FAUL THOMAS
IPC: G07F17/32
Filed: 2010-02-05
Abstract: The coin-operated entertainment equipment has a computer-controlled playing device (1) which consists of a circular body (2). The circular body is assigned with a projection device (4) to represent information on the circular body. The information is formed as symbols or gain lines (6). The projection device is formed as a computer-controlled laser line (8) to display gain lines.
Patent PT-2396225-E (PT)
Title: Packaging machine designed for the compression and packing of blocks of expanded material
Inventor: ZANINELLI DAVIDE
IPC: B65B9/02
Filed: 2010-02-10
Abstract: A packaging machine (10) designed and equipped for the compression and packing of blocks of expanded material and in particular expanded polyurethane where the machine comprises: a) an infeed block “A” comprising an infeed unit (11) mounted on wheels, which has a first lower infeed conveyor belt (12) and a second upper infeed conveyor belt (13) which is fitted with a first hydraulic press (14); b) a central block “B” containing a crossways sealing bar (15) operating with a cold sealing system and a powered lower reel holder (16) and a powered upper reel holder (17); c) a rear block “C” comprising a second out feed conveyor which in turn comprises an upper conveyor belt fitted with a central hydraulic press counter opposing a further lower conveyor belt (20), and two side sealing bars (21) employing a cold sealing system.
Patent PT-2431376-E (PT)
Title: Novel stable crystal of 1-(2'-cyano-2'-deoxy-beta -d-arabinofuranosyl)cytosine monohydrochloride
Inventor: WATANABE SHOTARO
IPC: A61K31/7068
Filed: 2010-05-14
Abstract: Disclosed is a stable crystal of 1-(2'-cyano-2'-deoxy-²-D-arabinofuranosyl)cytosine monohydrochloride. There is provided a crystal of l-(2'-cyano-2'-deoxy-²-D-arabinofuranosyl)cytosine monohydrochloride having characteristic peaks at 13.7°, 15.7°, 16.0°, 18.6°, 20.3°, and 22.7° as diffraction angles (2¸ ± 0.1°) measured by powder X-ray diffraction, and having a melting point of 192°C to 197°C..
Patent PT-702010-E (PT)
Inventor: RENARD PIERRE
IPC: A61P19/02
Filed: 1995-09-14
Abstract: Arylalkyl piperazino alkyl benzopyran derivs. of formula (I), their optical isomers and acid and base addn. salts, are new. Ar = phenyl or naphthyl (both opt. substd. by 1-3 OH, alkyl (opt. substd. by one or more halo), alkoxy or halo); n = 1-4; when Rb = alkyl, then A = bond and Ra, Rc = H, halo, alkyl (opt. substd. by one or more halo) or alkoxy; when Rb+Rc = -(CH2)q-, then A = -(CH2)p- and Ra = OH or alkoxy in position 5, or H or halo ; or when Rb+Rc = -CH= single bonded to the aromatic ring, then A = CH2 and Ra = H, OH or alkoxy in position 5; or Rb+Rc = bond, then A = -C(=O)-CH= and Ra = H, hydroxy or alkoxy; p = 0- 2; q = 0- 2; provided that p + q = 1 or 2; when Rb = alkyl, then X, Y = H; or CXY = CO and Rd = H or alkyl; when Rb+Rc = (CH2)2 or -CH= then X, Y = H and Rd = H; all alkyl, alkoxy = 1-6C.
Patent PT-793542-E (PT)
Inventor: SASAKI YASUHIKO
IPC: C09J7/38
Filed: 1995-09-14
Abstract: There is provided a laminate of a backing, a layer of permanent pressure-sensitive adhesive and a layer of removable pressure-sensitive adhesive, the latter being in contact with a release surface of a release liner or the opposed surface of the backing. The removable pressure-sensitive adhesive is provided at a coat weight of at least 10 gsm and at coat weight ratio to the permanent pressure-sensitive adhesive of at least 1:1.
Patent PT-811165-E (PT)
Inventor: HAAHEIM LARS REINHARDT
IPC: G01N33/569
Filed: 1996-02-21
Abstract: PCT No. PCT/GB96/00392 Sec. 371 Date Aug. 21, 1997 Sec. 102(e) Date Aug. 21, 1997 PCT Filed Feb. 21, 1996 PCT Pub. No. WO96/26443 PCT Pub. Date Aug. 29, 1996The present invention provides a method of detecting active antibody production in a blood sample by contacting, in the presence and absence of protein synthesis inhibitor, aliquots of the sample with a solid phase under conditions which permit antibody production and secretion by the lymphocytes; detecting in solution, binding of antibody to the antigen(s) on the solid phase; and comparing the antibody binding in the presence or absence of protein synthesis inhibitor, whereby to obtain a determination of the amount of active antibody secretion in response to the antigen(s); and kits for performing the method. The method may also be modified to allow detection of non-specific infection indicators.
Patent PT-937094-E (PT)
Inventor: ARLT DIETER
IPC: C07H17/08
Filed: 1997-10-20
Abstract: PCT No. PCT/EP97/05777 Sec. 371 Date Apr. 27, 1999 Sec. 102(e) Date Apr. 27, 1999 PCT Filed Oct. 20, 1997 PCT Pub. No. WO98/18806 PCT Pub. Date May 7, 1998The present invention relates to a process for preparing ivermectin by selective hydrogenation of avermectin and subsequent removal of the catalyst.
Patent PT-950386-E (PT)
Inventor: WRIGHT CAROL
IPC: A61F2/06
Filed: 1999-04-15
Abstract: A stent (30) comprises a coating containing rapamycin. The coating is formed from a polymer mixed carrier containing the rapamycin. The coating is applied to the stent.
Patent PT-1089998-E (PT)
Title: Epothilone derivatives and their synthesis and use
Inventor: NICOLAOU KYRIACOS COSTA
IPC: A61K31/365
Filed: 1999-06-21
Abstract: The invention relates to epothilone analog represented by the formula I   
wherein 
(i)  R 2   is absent or oxygen;  "a"  can be either a single or double bond;  "b"  can be either absent or a single bond; and  "c"  can be either absent or a single bond, with the proviso that if  R 2   is oxygen then  "b"  and  "c"  are both a single bond and  "a"  is a single bond; if  R 2   is absent then  "b"  and  "c"  are absent and  "a"  is a double bond; and if  "a"  is a double bond, then  R 2 , "b"  and  "c"  are absent;  R 3   is a radical selected from the group consisting of hydrogen; lower alkyl; -CH=CH 2 ; 
-C¡CH; -CH 2 F; -CH 2 CI; -CH 2 -OH; -CH 2 -O-(C 1 -C 6 -alkyl); and -CH 2 -S-(C 1 -C 6 -alkyl);  R 4   and  R 5   are independently selected from hydrogen, methyl or a protecting group; and  R 1   is as defined in the specification, or a salt of a compound of the formula I where a salt-forming group is present. A further aspect of the invention is related to the synthesis of epothilone E.  These compounds have inter alia microtubuli depolymerisation inhibiting activity and are e.g. useful against proliferative diseases.
Patent SG-110287-G (SG)
Title: Oprical fibre transmission lines
IPC: G02B6/04
Filed: 1987-12-26
Abstract: An optical fibre transmission line is installed by first installing a conduit (11) having one or more bores (12) and subsequently inserting flexible, lightweight optical fibre members (14) containing the optical fibres (22, 32) into the bores (12). 
<??>The optical fibre members (14) are propelled by employing the fluid drag of air, or another suitable gas, passed at high velocity through the bores (12).
Patent IE-880264-L (IE)
Title: Cinnoline derivatives-pharmaceutical compositions
IPC: C07D403/12
Filed: 1988-02-01
Abstract: The invention relates to compounds having the general formula (I)   <CHEM>  wherein  n is zero, 1 or 2;  each of R1 and R2 is independently:     a) hydrogen, halogen, trifluoromethyl or C1-C6 alkyl;   b) hydroxy, C1-C6 alkoxy or C3-C4 alkenyloxy;   c) nitro, amino, formylamino or C2-C8 alkanoylamino;  R3 represents hydrogen or C1-C8 alkyl;  R4 is:       a') C1-C20 alkyl, unsubstituted or substituted by <CHEM> wherein each of Ra and Rb is independently phenyl or C1-C6 alkyl, or Ra and Rb, taken together with the nitrogen atom to which they are linked, form a N-pyrrolidinyl, N-piperazinyl, hexahydroazepin-1-yl, thiomorpholino, morpholino or piperidino ring, wherein said heterocyclic rings may be unsubstituted or substituted by C1-C6 alkyl or phenyl;   b') C5-C10 cycloalkyl, unsubstituted or substituted by methyl; c') 2- or 3-pyrrolidinyl, piperidyl of 2-piperazinyl, wherein said heterocyclic rings may be unsubstituted or substituted by C1-C6 alkyl; d') isoxazolyl or thiazolyl, wherein said heterocyclic rings may be unsubstituted or substituted by C1-C6 alkyl; e') pyridyl, unsubstituted or substituted by one or two substituents chosen independently from halogen, C1-C6 alkyl and C1-C6 alkoxy; or f') phenyl, unsubstituted or substituted by one or two substituents chosen independently from halogen, CF3,C1-C6 alkyl, C1-C6 alkoxy, amino, nitro, formylamino and C2-C8 alkanoylamino, and the pharmaceutically acceptable salts thereof, which possess immunomodulating activity and are useful e.g. in the treatment of neoplastic diseases and acute and chronic infections of both bacterial and viral origin in mammals.
Patent IE-40828-L (IE)
Title: S- carboxymethyl - (thiono) - (di) - thiolphosphoric¹(phosphonic) acid esters and ester amides-insecticides
IPC: C07F9/165
Filed: 1975-03-14
Abstract: Substituted S-carboxymethyl-(thiono)-(di)-thiolphosphoric(phosphonic) acid esters and ester-amides of the formula XOR3 R1 PARALLEL ANGLE P-S-CH-CO2R4 (I), R2O in which R1 is phenyl, C1-C6 alkoxy, C1-C6 alkylmercapto, C1-C5 alkyl, alkoxyalkoxy with 1 to 5 carbon atoms in each alkyl moiety, C1-C5 alkylamino or C2-C5 alkenylamino, R2 is C1-C6 alkyl, alkoxyalkyl with 1 to 5 carbon atoms in each alkyl moiety or C5-C7 cycloalkyl, R3 is phenyl; cyclohexyl; C1-C7 alkyl; C1-C5 halogenoalkyl; or carbalkoxymethyl, aralkyl or alkoxyalkyl with 1 to 5 carbon atoms in each alkyl moiety, R4 is C1-C5 alkyl, phenyl or phenyl substituted by at least one of halogen, nitrile, nitro, C1-C4 alkyl and C1-C4 alkoxy, and X is oxygen or sulfur, WHICH POSSESS INSECTICIDAL PROPERTIES.
[US3973013A]
Patent IE-850612-L (IE)
Title: Inverse discrete cosine transform calculation processor
IPC: G06F17/14
Filed: 1985-03-08
Abstract: An inverse discrete cosine transform calculation processor, for processing television picture signals, comprises a processor module consisting of four successive stages. The first stage comprises a multiplier associated with a sine and cosine function value store which is connected to one of its input buses. Each of the other three stages comprises an adder/subtracter having two input buses each selectively connected to the output bus of the directly preceding stage or to the output bus of an input register of this stage also loaded from the output bus of the directly preceding stage and which features on the output bus of one of the input registers of the fourth stage an internal loopback bus which with an input bus of the module is selectively connected to the second input bus of the multiplier.
[US4679163A]
Patent IE-840979-L (IE)
Title: Acoutical panel
IPC: E04B/
Filed: 1984-04-19
Abstract: A panel having a cellular core and an acoustically semi-transparent facing is provided. The core, which may be a honeycomb, has cells opening to a face of the core. The facing is bonded to the face of the core such that pillow-like portions of the facing extend into the open cells of the core to provide a mechanical interlock between the facing and the core and to improve the absorption of acoustic energy directed upon the panel. The panel may include a layer bonded to the core opposite the facing for reducing the transmission of acoustic energy through the panel or for increasing its strength and rigidity. Preferably, the facing is non-homogeneous such that the density of the pillow-like portions is less than the portions of the facing adjacent the structure of the core. The panel may be formed by heating and compressing an uncured fibrous element of relatively uniform thickness and density against a cellular core. A heated platen may be used to produce a relatively flat, hardened outer surface of the panel.
[US4522284A]
Patent IE-37802-L (IE)
Title: Composite propellants
IPC: C06B45/10
Filed: 1973-06-15
Abstract: 1397523 Propellants SOC NATIONALE DES POUDRES ET EXPLOSIFS 4 July 1973 [5 July 1972] 31920/73 Heading C1D A propellent composition comprises by weight 78-92% of a chlorate or perchlorate of an alkali metal or alkaline earth metal, a binder which is a silicone rubber in an amount of 8- 14À6% or a cellulose acetate in an amount of 8-17À2%, and 0À1-0À8% of elemental carbon as a combustion regulator. The combustion regulator may be acetylene black or graphite. As an additional combustion regulator, copper dichromite may be added. Aluminium powder may be present as a combustion accelerator, and tricresyl phosphate, diethyl phthalate, or triacetin as a plasticizer. The composition produces non-toxic combustion gases and may be used in a gas generator of an inflatable cushion safety device in an automobile.
[GB1397523A]
Patent FI-810936-L (FI)
Inventor: CLAUSON-KAAS NIELS
IPC: C07D237/22
Filed: 1981-03-26
Abstract: 4-Chloro-5-amino-2-phenyl-3(2H)-pyridazinone is prepared from 4,5-dichloro-2-phenyl-3(2H)-pyridazinone and ammonia in high yield and substantially free from 4-amino-5-chloro- 2-phenyl-3(2 H)-pyridazinone in a method comprising reacting 4,5-dichloro-2-phenyl- 3(2H)-pyridazinone with aqueous ammonia in the presence of a catalyst (a phenolic compound) which is capable of selectively exchanging the 5-chlorine atom in 4,5-dichloro-2- phenyl-3(2H)-pyridazinone with a leaving group of such a nature that the resulting intermediate compound is capable of aklylating ammonia to 4-chloro-5-amino-2- phenyl-3(2H)-pyridazinone in high yield in the reaction medium, thereby regenerating the catalyst. The end product is isolated by filtration after the reaction and washed with water, and the mother liquor plus the wash water are used as reaction medium for the next batch.
Patent FI-811951-L (FI)
Inventor: AUGART HELMUT
IPC: A61K9/26
Filed: 1981-06-22
Abstract: A pharmaceutical composition with a retarded liberation of an active material and a process for producing the same are disclosed. An active material in finely divided form is mixed with both a finely divided high melting lipid or lipoid component and a finely divided low melting lipid or lipoid component, the resulting mixture is brought to a temperature which is above the melting point of the low melting component but below the melting point of the high melting component and the mixture, after melting of the low melting component, is allowed to cool to below the melting point thereof and subsequently worked up to give a finished pharmaceutical composition which has a controlled retarded liberation and which is safe, easy and not expensive to produce.
Patent IE-34777-L (IE)
Title: Handrail and drive for a passenger conveyor
IPC: B66B23/20
Filed: 1970-09-25
Abstract: 1291814 Escalator handrails GOODYEAR TIRE & RUBBER CO 16 Sept 1970 [13 Oct 1969] 44236/70, Heading B8A In the drive of a handrail for an escalator or moving walkway 3 the handrail 25 passes around a drive pulley 33 of similar size and attached to the shaft 15 of an end roller 8 of the escalator and has tensioning units 35, 36 disposed on opposite sides of the drive pulley 33 each operative for a different direction of motion of the walkway 3 to provide sufficient tension on the slack or downstream side of the drive pulley for driving the handrail in that direction. The tensioning unit 35 comprises an idler roller 37 mounted on a carriage (38), Fig. 2 (not shown), for movement along guide rails (39) under the effect of a spring unit (50) coupled to the carriage (38) by a cable (56). The idler pulley is canted out of the plane of the drive pulley 33 to allow maximum wrap round of the handrail about the idler and drive pulleys without reversal of the handrail. The tensioning unit 36 comprises a rack (70), Fig. 8 (not shown), slidable along rails (71), (72) and mounting roller (73) to bear against the underside of the handrail and urge the outer surface of the handrail against rollers (69) mounted on a convex frame (68). The tension is applied by weights 74 coupled to the rack (70) by a cable (75). Each tensioning unit has a stop (63), (76) to prevent excessive movement of the respective carriage (38) or rack (70) when the direction of movement of the handrail is such that the corresponding unit becomes disposed on the high tension or upstream side of the drive pulley.
[GB1291814A]
Patent IE-801339-L (IE)
Title: Preparation of optically active aryloxyalkanoic acids.
IPC: C07C201/00
Filed: 1980-06-27
Abstract: The invention relates to the preparation of optically active aryloxyalkanoic acid derivatives of the formula <IMAGE> in which Ar represents an optionally substituted phenyl, naphthyl, phenoxy or pyridyloxy radical, R represents a C1-C4-alkyl radical and A represents a -COOR1, <IMAGE> or -CO-Z radical, Z being halogen. It consists in reacting an aqueous or aqueous-organic solution of an optically active alkali metal salt of a 2-halogeno-alkanoic acid with an aqueous solution of an alkali metal salt of the phenol of the formula Ar-OH at an elevated temperature under a pressure less than the vapor pressure of water at the chosen temperature. It permits the preparation of aryloxyalkanoic acid derivatives with a very high content of the isomer having the D configuration, which can be used as herbicides.
[US4766220A]
Patent IE-33602-L (IE)
Title: Substituted piperidine
IPC: C07D211/34
Filed: 1969-10-17
Abstract: 1,234,359. Isonipecotic acid derivative. JANSSEN PHARMACEUTICA N.V. 31 Oct., 1969 [4 Nov., 1968], No. 53573/69. Heading C2C. The novel compound, 1 - (3 - cyano - 3,3- diphenylpropyl) - 4 - phenylisonipecotic acid, and its pharmaceutically acceptable acid addition salts, are prepared by hydrolysing a C 1-7 alkyl ester of said acid, and, if desired, converting the resulting acid into a pharmaceutically acceptable acid addition salt thereof. Pharmaceutical compositions having antidiarrheal and analgesic activity comprise the novel compound, or a pharmaceutically acceptable acid addition salt thereof, together with a pharmaceutical carrier. The compositions may be administered orally or parenterally, e.g. in the form of tablets, capsules, powders, suspensions, elixirs and solutions. Reference has been directed by the Comptroller to Specification 843,319.
[GB1234359A]
Patent IE-43260-L (IE)
Title: Benzoylureidodiphenyl ethers.
IPC: C07C275/54
Filed: 1976-07-09
Abstract: 2',4-Dichloro-4'-benzoylureido-diphenyl ethers of the formula <IMAGE> (I), in which R is chlorine, fluorine, bromine or methyl, and R' is hydrogen or chlorine, WHICH POSSESS INSECTICIDAL PROPERTIES.
[US4068002A]
Patent IE-831852-L (IE)
Title: Deacylation of an amide
IPC: C07D499/42
Filed: 1983-08-05
Abstract: Deacylation of Amides by the iminohalide iminoether process using long-chain bases.
Patent IE-842539-L (IE)
Title: Conjugates of metallothionein and biologically active¹molecules
IPC: A61K49/00
Filed: 1984-10-05
Abstract: Conjugates of target-seeking biologically active molecules and metallothionein in which all or part of the metal in the metallothionein is suitable for diagnostic or therapeutic applications.
[US4732864A]